Photocure $PHO.OL stock trade above resistance, close at 5yr hgh
Recent news by 
PHO:
Randomized phase 3 study in Denmark demonstrates significant advantage in Bladder Cancer for Hexvix/Cysview blue light cystoscopy over standard white light variant:
https://photocure.com/news/photocurefirst-trial-demonstrating-reduced-recurrence-after-flexible-blue-light-cystoscopy-with-hexvix-in-surveillance/
At Q3 2019 Photocure reported continued record growth in the US as well as upfront payments from Chinese partner Asieris:
https://photocure.com/news/photocure-asa-results-for-the-third-quarter-of-2019/
Further improvements for US reimbursements for Cysview from january 2020:
https://photocure.com/news/photocure-cysview-reimbursement-further-improved-from-january-2020/
Technical analysis:
Technical indicators sliding into high momentum and near overbought values at this price level, so any entry should be done with clear considerations of short term risks.
PHO:Randomized phase 3 study in Denmark demonstrates significant advantage in Bladder Cancer for Hexvix/Cysview blue light cystoscopy over standard white light variant:
https://photocure.com/news/photocurefirst-trial-demonstrating-reduced-recurrence-after-flexible-blue-light-cystoscopy-with-hexvix-in-surveillance/
At Q3 2019 Photocure reported continued record growth in the US as well as upfront payments from Chinese partner Asieris:
https://photocure.com/news/photocure-asa-results-for-the-third-quarter-of-2019/
Further improvements for US reimbursements for Cysview from january 2020:
https://photocure.com/news/photocure-cysview-reimbursement-further-improved-from-january-2020/
Technical analysis:
Technical indicators sliding into high momentum and near overbought values at this price level, so any entry should be done with clear considerations of short term risks.
Powiązane publikacje
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.